Experience of 40+ deals
Experience of 40+ deals with the total value of USD 1.3 bln
with the total value
of USD 1.2 bln
Leading M&A advisor in Russia
Home
M&A advisor in Russia
Leading
Key figures and results
2015
1000+
800+
40+
25
10
The total experience of key team members exceeds 40 years of M&A practice.
the company was founded in 2015
1000+ companies
800+ investors worldwide
40+ completed projects
10 industries in which deals have been successfully closed
We try to understand the client's tasks, we focus on a personal approach, we use the accumulated experience of all team members
Pharma 17, technology 18, agriculture 2, finance 1, construction 2, electrotechnical equipment 1, trade/distribution 1, automotive components 1, machinery 1, transport 1
25 transactions within 2021 – 2023
One of the main assets is access to 1000+ financial and industry investors from all over the world. This helps to quickly raise capital for growth, find buyers for assets, create competition between them, and maximize the value of the asset being sold.
in various sectors of the economy where we have access at the shareholder level.
This allows us to quickly and efficiently purchase assets for our clients.
Figures
About the company
Novus Capital is a team of investment market professionals focused on supporting M&A transactions and capital raising transactions aimed at business growth.
For 7 years of work, we have reached the leading positions in the M&A market of Russia in the pharmaceutical area by closing 17 transactions.
Russia M&A Awards: Best Russian Consultant, 2nd place
2021
о компании
About
Leader in the pharmaceutical
Industry Awards
Who works with us
Services
01
M&A transaction support
02
Capital raising for business development
Services
01
Support of mergers and acquisitions (M&A) transactions
In M&A transactions we:
Novus Capital provides a full range of advisory services in M&A transactions: sale and acquisitions of companies/assets, devision of the companies and mergers.
Our team engages industry experts and market specialists that helps us evaluating the rationale and deal probability.
02 identify potential investors that are interested to acquire (in case of sell-side engagements) or acquisition targets that are interested to be acquired (in case of buy-side engagements)
01 prepare marketing materials (investment teaser, information memorandum and other presentation materials)
03 organize the negotiations process
04 help to agree on deal terms
Thanks to our deep industry knowledge and understanding of the specifics of the industries in which we operate, our team has built long-term relationships with the top management and shareholders of Russian and international companies, as well as with other key market participants (media, regulators and public organizations).
All these factors together allow us to participate in the most significant M&A transactions in the Russian market.
02
Capital raising for business development
In capital raising we:
Novus Capital advises in capital raising transactions for companies willing to finance its development. We help determining the necessary size of the investment capital, optimal split between equity and debt financing, deal structure as well as the list of the most probable investors/lenders.
01 prepare the documents for the tender process among the potential investors (investment teaser, information memorandum and other presentation materials)
03 solicit the offers from the potential investors and analyse them
04 help to agree on deal terms
02 contact potential investors and present the business plan of the company
Purposes to retain Novus Capital
01
Sell business
02
Buy a business
03
Scale business by raising capital
04
Find business partners
Purposes of retention
Selected credentials
Deals
Year
Industry
Side
Deal type
All
All
All
All
Metallurgy
2023
Sale of Oskolsky plant of metallurgical machinery (OZMM
Novus Capital acted as the exclusive sell-side financial advisor in the process of selling Oskolsky plant of metallurgical machinery, one of the leading manufacturers of spare parts for mining, processing, and metallurgical equipment in Russia. Our team organized a competitive closed auction process, negotiated the deal conditions documentation and its closing. This is a first deal closed by Novus Capital in the metallurgy industry. The company was bought by United Metallurgical Company.
2023;Metallurgy;Sell-side;Sale of business
EduTECH
2023
Sale of ProductStar company
Novus Capital acted as a sell-side advisor in the process of selling ProductStar (an EduTech platform providing product management, analytics, programming, and other demanded digital-courses). The company was bought by mediaholding RBC.
2023;EduTECH;Sell-side;Продажа бизнеса
Finance
2023
Sale of CNH Financial Business in Russia
Novus Capital acted as the sell-side advisor for the global agricultural and industrial equipment manufacturer CNH Industrial in the process of selling to ExpoCapital its financial business in Russia that included two companies: leasing and factoring. Novus Capital organized a competitive closed auction process that resulted in the successful closing of the transaction. CNH reported in its press statement following the deal that the divestiture of its business activities in Russia was for a total consideration of approximately USD 60 million (including the operational business).
2023;Finance;Sell-side;Sale of business
Machinery
2023
Sale of CNH Industrial Operational Business in Russia
Novus Capital acted as the sell-side advisor for the global agricultural and industrial equipment manufacturer CNH Industrial in the process of selling its operational business in Russia through the management buy-out transaction. Its footprint included manufacturing sites for agricultural equipment and implements and construction equipment, and a parts depot. For the fiscal year ending 2021, the last full year of operations, the Russian operations generated revenue of approximately USD 380 million, representing 2% of the Company’s consolidated revenue in 2021. Novus Capital advised CNH in structuring the transaction and conducting the negotiations process that led to the successful closing of the deal.
2023;Machinery;Sell-side;Sale of business
Automotive components
2023
Sale of Grupo Antolin business in Russia
Novus Capital acted as financial advisor to the Spanish Grupo Antolin, an international manufacturer of automotive components for interiors and a global headliner supplier, in the process of selling to an industrial investor. Grupo Antolin's Russian business was represented by two production sites based in St. Petersburg and Nizhny Novgorod. Novus Capital organized a competition among potential buyers, conducted negotiations, agreed on the documentation for the transaction and its closure.
2023;Automotive components;Sell-side;Sale of business
Transport
2023
Sale of GATX Corporation's business in Russia
Novus Capital acted as sell-side financial advisor to American company GATX Corporation, rail track leasing operator, in the sale of operations in Russia to a private investor. Novus Capital organized competition among potential buyers, negotiated the deal conditions, documentation and its closing. This is a first deal closed by Novus Capital in railcar leasing industry.
2023;Transport;Sell-side;Sale of business
Pharma
2023
Sale of a portfolio of Axobrex, Luxidropin, Seltaren, Xedrenio, Ypnomakt products in Poland
Novus Capital acted as a financial advisor to Unipharm in the sale of a portfolio of products known on the Polish pharmaceutical market. The deal will allow Fidia to expand its presence in Europe and enter the new Polish market.
2023;Pharma;Sell-side;Sale of business
Packaging
2022
Sale of Amcor's business in Russia
Novus Capital acted as the sell-side financial advisor for Amcor in the sale of its business in Russia, which included two plants of specialty folding cartons for tobacco products and one plant of flexible packaging for pet food. Our team has organized and lead a competitive closed auction process, which resulted in the successful transaction with the new owner of the companies.
2022;Packaging;Sell-side;Sale of business
Technology and venture investments
2022
Capital raising
Biomicrogel Group is an innovative company established in 2012 by a team of engineers who developed a unique technology for cleaning water and hard surfaces from any types of oils, petroleum products, and integrated pollutions. Novus Capital acted as a financial advisor to thr founders in raising of financing.
2022;Technology and venture investments;Sell-side;Capital raising
Electrotechnical equipment
2022
Sale of Shares of JSC “SESH Holding” owned by Schneider Electric Industries SAS
Novus Capital acted as the sell-side financial advisor for Schneider Electric Industries SAS and organized a competitive closed auction process.
This is Novus Capital's yet another transaction with a multinational company as a client.
2022;Electrotechnical equipment;Sell-side;Sale of business
Pharma
2022
Sale of Ballamin and Streboxar in Poland
Novus Capital acted as the sell-side financial advisor for Unipharm in the process of sale of Ballamin and Streboxar products to the German company Klosterfrau Healthcare Group.
2022;Pharma;Sell-side;Sale of business
Agriculture
2022
Sale of Russian Linen company to Melkom
Novus Capital acted as financial advisor during the transaction on the Seller's side. Our team advised the Seller at all stages of the transaction, particularly in negotiations with buyers, accompanied by due diligence, in coordinating binding documentation for the transaction in parallel with several parties. This transaction is the 37th successfully completed project of Novus Capital.
2022;Agriculture;Sell-side;Sale of business
Pharma
2022
Sale of two anti-bacterial brands Ciprolet and Levolet in Russia, Belarus, and Uzbekistan
Novus Capital acted as the sell-side financial advisor for Dr. Reddy's Laboratories in all phases of the transaction, specifically in preparation of investment materials, negotiations with buyers, support in due diligence, and agreeing on definitive transaction documentation.
2022;Pharma;Sell-side;Sale of business
Pharma
2021
Acquisition of Neuromexol product
Novus Capital acted as a financial advisor to Geropharm, a national manufacturer of biotechnological products, in the process of purchasing a product for the treatment of anxiety disorders and syndrome of vegetative dystonia Neuromexol.
2021;Pharma;Buy-side;Acquisition
Pharma
2021
AMFITA
The company, which specializes in the development, production and sale of synbiotic preparations based on bifidobacteria and lactobacilli in combination with other biologically active components - prebiotics, vitamins, minerals, etc.
Novus Capital acted as a financial advisor to a group of private investors
2021;Pharma;Sell-side;Sale of business
Pharma
2021
DIALAB
DiaLab Plus LLC is a laboratory that performs over 2400 studies of a wide range from the most frequent to the most rare (departments of genetics and cytogenetics, immunological, microbiological and others). It has been successfully operating in the market since 2003.
Novus Capital acted as a financial advisor to the founders in raising of financing
2021;Pharma;Sell-side;Capital raising
Technology and venture investments
2021
NAYM
Enterprise platform for remote hiring of vetted IT specialists. The company overtook the search and the vetting. Thus the whole process of hiring outstanding international teams is now ten-fold faster and easier for everyone involved.
Novus Capital acted as a financial advisor to the founders in raising of financing
2021;Technology and venture investments;Sell-side;Capital raising
Technology and venture investments
2021
LOSHIP

Established in 2014, Loship is Vietnam’s fastest-growing one-hour-delivery E-commerce startup. The team works toward the mission of fulfilling every instant delivery need of Vietnamese people. Currently, the firm runs a fleet of more than 70,000 drivers serving 2 million customers across five major cities in Vietnam.
Novus Capital acted as a financial advisor to the founders in raising of financing
2021;Technology and venture investments;Sell-side;Capital raising
Technology and venture investments
2021
VOICEITT
A speech recognition app for people with speech disorders. Designed by experts in algorithms and linguistics, Voiceitt learns your unique speech patterns. By using statistical modeling and machine learning, Voiceitt improves every time you use it.
Novus Capital acted as a financial advisor to the founders in raising of financing
2021;Technology and venture investments;Sell-side;Capital raising
Technology and venture investments
2021
REFIN.ONLINE
Refin.online is a Russian fintech startup that develops a digital platform for mortgage management. The company helps borrowers to refinance mortgages remotely, takes care of all the work with documents and the bank, advises and fully accompanies the client before the transaction. The company is an accredited partner of 20 key Russian banks.
Novus Capital acted as a financial advisor to the founders in raising of financing
2021;Technology and venture investments;Sell-side;Capital raising
Technology and venture investments
2021
WOWCUBE
A US company that created a miniature WowCube game cube, reminiscent of the Rubik's Cube, and an ecosystem for the development of publishing and selling applications for the cube. The toy is equipped with 8 microprocessors and 24 screens. The cube can be loaded with applications from a smartphone on iOS or Android via Bluetooth.
Novus Capital acted as a financial advisor to the founders in raising of financing

2021;Technology and venture investments;Sell-side;Capital raising
Technology and venture investments
2021
Essense Investment AG
A swiss cannabis holding with 50+ years of combined experience in Research, Product development, Brand and Marketing, Distribution and Retail, including Phyto Pharmaceuticals and Wellness. Essence Investment AG invests in companies and technologies related to cannabis industry.
Novus Capital acted as a financial advisor to the founders in raising of financing
2021;Technology and venture investments;Sell-side;Capital raising
Technology and venture investments
2021
ANGARA
The world’s pioneer in Cognitive Cleaning technology, Angara helps its clients meet their net zero emissions targets, and uplift their processing margins- by reducing fossil fuel energy use through boosting the performance of their heat exchanging equipment.
Novus Capital acted as a financial advisor to the founders in raising of financing
2021;Technology and venture investments;Sell-side;Capital raising
Technology and venture investments
2021
MYOS
Myos acts as a financial investor for German and Austrian companies selling their products online. Since 2018, the company has successfully funded and helped develop more than 1000 businesses.
Novus Capital acted as a financial advisor to the founders in raising of financing
2021;Technology and venture investments;Sell-side;Capital raising
Technology and venture investments
2021
Aripix Robotics
Aripix Robotics is a Russian company specializing in the development, production and installation of 6-axis industrial robotic arms for small, medium and large enterprises around the world. Robots allow you to automate cyclical routine operations in factories and are in demand in many industries, increase production efficiency, raise labor productivity, etc.
Novus Capital acted as a financial advisor to the founders in raising of financing
2021;Technology and venture investments;Sell-side;Capital raising
Technology and venture investments
2021
CAROUSEL
Carousel is a Russian electric scooter sharing company that provides unique durable scooters for rent with a large drive range (up to 40 km on a single charge). At the moment the Company is present in five cities of the Russian Federation.
Novus Capital acted as a financial advisor to the founders in raising of financing
2021;Technology and venture investments;Sell-side;Capital raising
Pharma
2020
Sale of nasal sprays Momat Rino and Momat Rino Advance
Novus Capital acted as the financial advisor to Glenmark Pharmaceuticals and organized a highly competitive closed auction process. In line with the strategy to launch Ryaltris, the global anti-allergy brand, in the markets of Russia and other CIS countries, Glenmark Pharmaceuticals Ltd. decided to divest the Momat Rino brand and its extensions in Russia, Ukraine, Kazakhstan and Uzbekistan
2020;Pharma;Sell-side;Sale of business
Pharma
2020
Raising equity financing for ASNA GROUP

Novus Capital acted as the financial advisor to ASNA Group in the process of raising equity financing from JSC Gazprombank. ASNA Group is the №1 player on the Russian retail pharmaceutical market that unites approximately 11.5 thousand independent pharmacies
2020;Pharma;Sell-side;Capital raising
Pharma
2020
Sale of TEVA’S PHARMACEUTICAL plant in russia
Novus Capital acted as the financial advisor to Teva Pharmaceuticals in the process of attracting buyers and facilitating negotiations with them. Teva Pharmaceuticals made a decision to sell its pharmaceutical plant in Russia (city of Yaroslavl) as a part of the general program for the restructuring of its production infrastructure
2020;Pharma;Sell-side;Sale of business
Technology and venture investments
2020
RADLOGICS
RADLogics develops AI-Powered solutions that support image analysis to improve radiologists’ productivity while enhancing patient outcomes.
Novus Capital acted as a financial advisor to the founders in raising of Round B financing
2020;Technology and venture investments;Sell-side;Capital raising
Technology and venture investments
2020
LOLOCLO
LOLOCLO is a Russian startup showing rapid growth in the children’s clothes segment. The company manufactures and sells all basic wardrobe for children from 0 to 12 years old using the DTC promotion model.
Novus Capital acted as a financial advisor to the founders in raising Round A financing
2020;Technology and venture investments;Sell-side;Capital raising
Technology and venture investments
2020
POLYN TECHNOLOGY
Polyn Technology is a high-tech startup that has developed a mathematical algorithm that allows converting almost any trained neural network into a package of technical documentation and then “print” such a network “on silicon” in the form of a neuromorphic analog chip.
Novus Capital acted as a financial advisor to the founders in raising seed round of financing
2020;Technology and venture investments;Sell-side;Capital raising
Technology and venture investments
2020
PRIVATE PLACEMENT and capital raise for Genotek
2020;Technology and venture investments;Sell-side;Capital raising
Novus Capital acted as a financial adviser for the shareholders of Genotek, one of the leading DNA testing companies in Russia in raising capital and a private placement
Pharma
2019
Divesture of Oralsept product line to GEDEON RICHTER

Novus Capital acted as a financial advisor in the transaction on the side of Salvim LLC. As a result of negotiations in November 2019, Salvim LLC and Gedeon Richter Plc signed an agreement to sell Oralsept product line.
2019;Pharma;Sell-side;Sale of business
Pharma
2019
Acquisition of product from PROFIT PHARM
Novus Capital acted as the financial adviser for Unipharm, a leading regional OTC company, in the acquisition of melatonin based product on the Russian market from Profit Pharm
2019;Pharma;Buy-side;Acquisition
Pharma
2018
Raise of Equity Financing for ACTIVE COMPONENT
Novus Capital acted as a financial advisor to the owners of the Russian company Active Component in a process of selling of a stake to Elbrus Capital (Private Equity Fund). Active component is the leading manufacturer of active pharmaceutical ingredients in Russia.
2018;Pharma;Sell-side;Sale of business
Pharma
2017
Sale of ALSI PHARMA
Novus Capital acted as the financial adviser for the owners of Russian company ALSI Pharma in the sale to the strategic investor Xantis Pharma. ALSI Pharma is a leading company in Russia manufacturing generics. The company specilizes in production of cardiovascular products and drugs for cenral nervous system.
2017;Pharma;Sell-side;Sale of business
Pharma
2016
Divesture of DOLPHIN BRAND portfolio

Novus Capital acted as financial advisers for the owners of Dolphin product line, a leading over-the-counter product (medical device) for the treatment of sinusitis (infections of the paranasal sinus) in Russia, in business sale to American company Alvogen
2016;Pharma;Sell-side;Sale of business
Pharma
2015
Sale of ORVIREM BRAND
Novus Capital team advised the owners of Russian pharmaceutical company Diod on sale of rights for Orvirem, ARVI and flu cure drug, to american company Alvogen
2015;Pharma;Sell-side;Sale of business
Pharma
2015
Acquisition of manufacturing facility in Lithuania
Novus Capital team advised the owners of Russian pharmaceutical company Materia Medica on the acquisition of a pharmaceutical manufacturing company in Lithuania from Valeant Pharmaceuticals International
2015;Pharma;Buy-side;Acquisition
Technology and venture investments
2014/2015
JV IN PHARMACEUTICAL COMMUNICATIONS BETWEEN AARON LLOYD AND DENTSU AEGIS NETWORK

Novus Capital acted as the financial advisor to a leading Russian pharmaceutical communication agency Aaron Lloyd in the creation of the joint venture in Russia with the leading global communications agency Dentsu Aegis Network
2015;Technology and venture investments;Sell-side;Sale of business
Pharma
2014
DIVESTURE OF AQUALOR BRAND PORTFOLIO TO STADA ARZNEIMITTEL AG

Novus Capital partners acted as the financial advisors to the owners of Aqualor brand, the leading over-the-counter product for rinsing the nasal cavity on the Russian market, in selling the product to the strategic investor
2014;Pharma;Sell-side;Sale of business
Pharma
2012
Divesture of FIVE BRANDS' portfolio
Novus Capital partners acted as the financial advisors to Akvion, one of the leading manufacturers of food supplements and pharmaceutical products on the Russian market, in selling the portfolio of five products to the strategic investor
2012;Pharma;Sell-side;Sale of business
Technology and venture investments
2012
Sale of PHARMEXPERT GROUP’S intellectual property
Novus Capital partners acted as the financial advisors to Pharmexpert Group, the leading analytical company for the pharmaceutical industry in Russia, in negotiations, structuring and closing the sale of its business to IMS Health - a leading provider of information, services and technology for the healthcare industry globally
2012;Technology and venture investments;Sell-side;Sale of business
Free consultation
Free consultation for those who want to raise capital, sell a company or buy a business.
01 Understanding your task;
02 Finding ways to solve it;
03 Offering our terms of cooperation.
The agenda of the meeting:
Consultation
The team
Sergey Orekhov
Nickolai Demidov
Aleksandr Lobakov
Denis Azhgirevich
Partner
Partner
Managing Partner
Director

>
<
The team
The team
Sergey Orekhov
Nickolai Demidov
Aleksandr Lobakov
Denis Azhgirevich
Partner
Partner
Managing Partner
Director

>
<
The team